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Three cDNAs, termed EpC1, TPxEg and EgG5, were isolated by immunoscreening from an Echinococcus granulosus cDNA library. The 
recombinant phages exhibited strong reactivity with sera from humans with confirmed cystic echinococcosis (CE) and with sera from 
mice infected with E. granulosus oncospheres. The cDNAs were subcloned into a pET vector, expressed as fusion proteins tagged with 
GST and affinity purified against the GST tag. Of the three recombinant proteins, EpC1 achieved the highest performance for 
serodiagnosis of CE in Western blot analysis using a panel of clinically defined human sera to initially address the sensitivity and 
specificity of the molecules. The protein yielded an overall sensitivity of 92.2% and specificity of 95.6%, levels unprecedented taking 
into account the large panel of 896 human sera that were tested. The strategy used may also prove suitable for improved 





Parasites, especially helminth worms, generally produce 
longstanding chronic infections. The elevated levels of serum 
antibodies that are generated during the course of infection can 
provide a sound basis for the development of sensitive and 
specific serodiagnostic methods for parasite detection. 
Nevertheless, serodiagnosis of a number of helminthic infections, 
such as cystic echinococcosis (CE), remains a challenge. The 
major problem is that crude or secretory/excretory proteins from 
the targeted parasite are often cross-reactive with sera from 
humans and animals infected with other parasites; this results in 
low specificity in the performance of serodiagnostic assays.  
 
CE is a near-cosmopolitan zoonosis caused by larval stages of the 
dog tapeworm (cestode) Echinococcus granulosus (family Taeniidae; 
genus Echinococcus). Larval infection (also termed hydatid disease; 
hydatidosis) is characterized by long term growth of metacestode 
(hydatid) cysts in the internal organs (mainly the liver and lungs) 
of humans and herbivorous (sheep, cattle, pigs goats, camels) 
intermediate hosts. Definitive hosts, such as dogs, wolves and 
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foxes, harbour the adult tapeworms in their intestines. 
Periodically these worms release segments and eggs that are 
passed in the faeces into the external environment. Eggs are 
ingested by humans and ungulates and the oncosphere larvae that 
are released penetrate the gut and are transported through blood 
or lymph to target organs (generally the liver or lungs). There 
they develop into hydatid cysts. Carnivores are infected by eating 
ungulate offal harbouring hydatid cysts containing viable brood 
capsules and protoscoleces. 
 
Early diagnosis of CE can provide significant improvements in 
the quality of the management and treatment of the disease. 
Generally, the early phases of infection are asymptomatic, so 
methods that are relatively easy to use and that are cheap are 
required for large scale screening of populations at high risk (1). 
Immunodiagnosis is considered to be a useful approach that can 
also confirm clinical findings based on the identification of cyst 
structures by imaging techniques such as ultrasonography (2-6). 
 
E. granulosus hydatid cyst fluid (HCF) antigens are the usual 
source of antigenic material for immunodiagnostic assays (6). 
However, there are difficulties associated with the currently 
available tests, related to their lack of sensitivity and specificity, 
and problems with the standardization of their use (7). Antibody 
cross-reactivity with antigens from other parasites, notably other 
taeniid cestodes, is a major problem when using HCF antigens in 
CE immunodiagnosis. It has been suggested that CE serology 
may be improved by the use of recombinant proteins, combining 
several defined antigens (including synthetic peptides) and the 
design of new E. granulosus-specific peptides that react with 
otherwise false-negative sera (6). We recently reported a novel 
DNA sequence from E. granulosus (termed EpC1) that was 
isolated from a protoscolex (larval) cDNA library by 
immunoscreening (8). The sequence was expressed in bacteria, 
purified and the value of the recombinant protein in diagnosis of 
human CE assessed. Here we report further on the strategy that 
we used to isolate this and other E. granulosus cDNAs, their 
expression and purification, and evaluation of their 
serodiagnostic performance. 
 




Sheep hydatid cysts were obtained from a slaughterhouse in 
Urumqi, Xinjiang, PR China. Hydatid cyst fluid (HCF) was 
collected from fertile cysts with a syringe and used for crude 
antigen preparation (see below). Then, brood capsules and 
protoscoleces were aspirated and washed 10 times with 
phosphate buffered saline (PBS). The brood capsules and 
protoscoleces were aliquoted into tubes and stored in liquid 
nitrogen until used. 
 
Activated oncospheres for infection of mice 
 
Mature adult worms were collected from dogs experimentally 
infected with fresh protoscoleces at Xinjiang Veterinary Research 
Institute, Urumqi. Eggs were released by homogenizing the 
worms in an electric blender. The homogenate was passed 
through a 132 µm sieve and the sheared worm material was 
discarded after thoroughly rinsing the worm tissues through the 
sieve. The eggs were further washed and retained on a 20 µm 
mesh. The washed eggs were stored in PBS containing 1000 
i.u./ml benzyl penicillin and 1000 µg/ml streptomycin sulphate at 
4°C (9). 
 
Eggs were incubated in 50 ml screw-capped tubes at 37°C for 45 
min in a sterile solution of 1% (w/v) pepsin (Sigma, St. Louis, 
MO, 1:2500) and 1% (v/v) HCl in 0.85% NaCl (w/v). After 
centrifugation (500 × g, 5 min), the pepsin solution was decanted. 
The eggs were washed once with PBS and incubated in a sterile 
solution of 1% (w/v) pancreatin (Sigma, 4 × U.S. Pharmacopeia.), 
1% (w/v) NaHCO3 and 5% (v/v) sterile sheep bile. The 
oncospheres were checked every 2 min with a microscope until 
all the oncospheres had been released from embryonic 
membranes. The oncospheres were pelleted by centrifugation 
(1,000 × g, 5 min). The supernatant was discarded and the 
oncospheres were washed twice with Hank’s buffer.  
 
The oncospheres were further purified by density-gradient 
separation with 100% Percoll (Sigma) (10). After washing 3 times 
with PBS, the supernatant was discarded and the oncospheres 
were used directly to infect mice. 
 
Infection of mice and preparation of mouse 
infection sera (MIS) 
 
Twenty-six (15 females, 11 males, 6-8 weeks old) Chinese 
Kunming White (CKW) mice were used for challenge infection 
with hatched/activated oncospheres (AO) (9) and production of 
antisera. The mice were infected with 2,500 AO injected 
intraperitoneally (i.p.), 500 AO injected intravenously (i.v.) or by a 
combination of both routes. The mice were sacrificed using CO2 
at 26 weeks after the first infection and the fluid-filled cysts (none 
had protoscoleces) present in the peritoneal and/or thoracic 
cavities were individually counted and measured for size. One 
individual was found to be uninfected. Blood samples were 
collected by heart puncture from the other 25 mice and sera were 
separated from clots by centrifugation at 12,000 × g for 3 min 
after placing the samples at 4°C for overnight. The sera were 
stored at -20°C until use. 
 
Preparation of hyper immune rabbit serum (HIRS) 
raised against HCF 
 
HCF was collected from fertile hydatid cysts as described above 
and dialyzed against PBS (10 × the volume of HCF) for 48 h at 
4ºC, with 8 changes of PBS. The HCF was concentrated ten-fold 
using the Tangential Flow Filtration (TFF) system (Millipore, 
Bedford, MA) and kept at -80°C until used. 
HIRS was produced by immunization of an outbred rabbit (Lop 
Hybrid) with HCF antigens. HCF proteins (400 µg) were mixed 
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with an equal volume of Freund’s complete adjuvant (Difco 
Laboratoies, Detroit, MI) for the first immunization given 
subcutaneously, and mixed with incomplete adjuvant for the 
second intramuscular immunization 3 weeks after the first 
injection. Two subsequent immunizations were carried out as for 
the second but at fourteen day intervals. The rabbit was ear-bled 
and the blood was clotted at room temperature for 30 min and 
then at 4°C for 4 h. The clot was separated from the serum by 
centrifugation at 3,000 × g for 10 min, and the serum stored in 1 
ml aliquots at –20°C after being pre-adsorbed against E. coli 




Total RNA was extracted from protoscoleces of E. granulosus freshly 
isolated from sheep hydatid cysts using TRIZOL Reagent 
(Lifetechnologies, Rockville, MD). Messenger RNA was extracted 
from 2 mg of total RNA using an Oligotex mRNA Mini Kit 
(Qiagen, Hilden, Germany). The mRNA was then precipitated by 
adding 1/10 vol of 3 M sodium acetate (pH 5.2), and 0.8 vol of 
isopropanol. The tube was kept at -20°C overnight, then 
centrifuged at 12,000 × g for 30 min at 4°C. The pellet was 
washed with 70% (v/v) ethanol, air-dried at room temperature 
10-15 min, and dissolved in 20 µl DEPC-treated water. The 
resulting mRNA was used for constructing the cDNA library. 
 
Construction of a protoscolex cDNA library 
 
The cDNA library was constructed using the ZAP Express® 
cDNA Synthesis Kit (Stratagene, La Jolla, CA). Briefly, first 
strand cDNA was synthesized commencing with 5 µg (in 25 µl 
of water) of poly(A)+ RNA in a final reaction volume of 50 µl 
containing 5 µl of 10 × first-strand buffer, 3 µl of first-strand 
methyl nucleotide mixture, 2 µl of  EcoR I adapters (1.4 µg/µl), 
12.5 µl  of  DEPC-treated water, and 1µl of RNase Block 
Ribonuclease Inhibitor (40 U/µl) (Stratagene). The reaction was 
incubated to anneal the primer to the template for 10 min at 
room temperature. 1.5 µl of MMLV-RT (50 U/µl) (Stratagene) 
was added to the first-strand synthesis reaction. Then, the 
reaction was further incubated at 37°C for 1 h. 
 
Second-strand cDNA synthesis was performed in a reaction 
volume of 200 µl containing 50 µl of the first-strand synthesis 
reaction, 20 µl of 10 × second-strand buffer, 6 µl of second-
strand dNTP mixture, 109 µl of sterile distilled water, 2 µl of [α-
32P] dATP (800 Ci/mmol, Amersham Pharmacia Biotech. Inc., 
Piscatway, NJ), 2 µl of  RNase H (1.5 U/µl) and 11 µl of DNA 
polymerase I (9.0 U/µl ) (all supplied by Stratagene). The mixture 
was incubated for 2.5 h at 16°C. 
 
Blunting the cDNA termini was carried out by adding 23 µl of 
blunting dNTP mixture and 2 µl of cloned pfu DNA polymerase 
(2.5 U/µl) to the second-strand synthesis reaction and incubating 
the reaction at 72°C for 30 min. The reaction was extracted by 
phenol-chloroform (1:1 (v/v), pH 7.5) and then chloroform. The 
cDNAs were precipitated by adding 1/10 volume of 3 M sodium 
acetate (pH 5.2), 2.5 volumes of 100% (v/v) cold ethanol at -
20°C overnight and microcentrifugation at maximum speed for 
60 min at 4°C. The pellet was washed with 70% (v/v) ethanol. 
The cDNA pellet was resuspend in 9 µl of EcoR I adapters (0.4 
µg/µl) (Stratagene) and incubated at 4°C for 30 min. Seven µl of 
the cDNA solution containing EcoR I adapters was transferred 
into a fresh tube followed by adding 1 µl of 10 × ligase buffer, 1 
µl of 10 mM rATP and 1 µl of T4 DNA ligase (4U/µl) (all 
supplied by Stratagene). The reaction was incubated overnight at 
8°C to ligate the adapters to cDNA. Then the tube was heated in 
a 70°C water bath for 30 min and then the reaction was cooled at 
RT for 5 min.  
 
The cDNA containing EcoR I ends was phosphorylated by 
adding 1 µl of 10 × ligase buffer, 2 µl of 10 mM rATP, 6 µl of 
sterile water and 1 µl of T4 polynucleotide kinase (all supplied by 
Stratagene), and incubating at 37°C for 30 min. The kinase was 
inactivated by heating at 70°C for 30 min, then the reaction 
allowed to equilibrate to RT for 5 min. 3’ termini was cut by Xho 
I restriction enzyme as the Oligo(dT) linker-primer containing 
the enzyme cutting site with adding 28 µl of Xho I buffer 
supplement and 3 µl of Xho I (40 U/µl) (all supplied by 
Stratagene).Then the reaction was incubated at 37°C for 90 min, 
the cDNA was precipitated by adding 1/10 volume of 10 × STE 
buffer and 2.5 volume of 100% (v/v) ethanol overnight at -20°C 
and the reaction mix centrifuged at maximum speed for 60 min at 
4°C. The pellet was resuspended in 14 µl of 1 × STE buffer and 
3.5 µl of the column loading dye. 
 
In order to obtain larger fragments, the cDNA was fractionated 
through a drip column containing Sepharose CL-2B gel filtration 
medium. The cDNA was run and eluted through the column by 
adding 1 × STE buffer and fractionated by the size of the cDNA. 
Larger fragments run faster than the smaller fragments. The size 
of cDNAs in each fraction was inspected by running 1 µl of each 
fraction (100 µl volume) on an agarose gel and exposing to an X-
Ray film (Fig. 2). Fractions containing cDNAs more than 500 bp 
in size were combined, then extracted with phenol-chloroform, 
chloroform, and precipitated with ethanol. The pellet was 
suspended in 10 µl of water and stored at -20°C until the next 
stage.  
 
The cDNAs were ligated into the ZAP Express vector 
(Stratagene) in a final volume of 5 µl containing 1 µl of the ZAP 
Express vector (1 µg/µl), 2 µl of cDNA (about 200 ng), 0.5 µl of 
10 × ligase buffer, 0.5 µl of 10 mM rATP (pH 7.5), 0.5 µl of 
water and 0.5 µl of T4 DNA ligase (4 U/µl) (all supplied by 
Stratagene). The reaction mixture was incubated overnight at 
12°C.  
 
Packaging of the cDNA library was performed by adding 1 µl of 
the ligated cDNA to 25 µl of packaging extract and incubation at 
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22°C for 2 h. Then 500 µl of salt and magnesium (SM) buffer 
and 20 µl of chloroform were added. After a brief microfuge 
spin, the supernatant containing the phage was ready to be titered 
and storing at 4°C for screening and amplifying.  
 
A small amount (1 µl) of stock lambda phage was serially diluted 
with SM buffer. One µl of the dilution was added to a tube 
containing 200 µl of host XL1-Blue cells cultured to an OD600nm of 
1.0 and diluted in 10 mM MgSO4 to an OD600nm of 0.5. After the 
tube was incubated at 37°C for 15 min, 3 ml of NZY top agar 
(melted and cooled to 48°C), 15 µl of 0.5 M IPTG (in water), and 
50 µl of X-gal {250 mg/ml [in N,N′-dimethyl-formamide 
(DMF)]} were added. The mixture was plated on the top of a 
NZY agar plate. The plate was cooled at RT for 10 min and then 
inverted and incubated at 37°C. The phage plaques could be seen 
visible after 6-8 h. The recombinants that were in a white (clear) 
background and non recombinants that were in a blue 
background were counted. The integrity of the library [in plaque-
forming units (pfu) per milliliter (pfu/ml)] was calculated using 
the formula: 
 
[Number of plaques (pfu) × dilution factor/volume plated (µl)] × 
1000 µl / ml. 
 
Immunoscreening the cDNA library 
 
The protoscolex cDNA library was immunoscreened using 
the hyper immune rabbit serum (HIRS) and a pool of the 
mouse infection sera (MIS). Briefly, XL1-blue host cells 
(Stratagene) were incubated with 1 µl of an optional dilution of 
the library, and plated on NZY agar plates. The agar plates were 
incubated at 42°C for 4.5 h, transferred to a 37°C incubator and 
overlaid with 10 mM IPTG-nitrocellulose membranes. The 
membranes were orientated on the plates using a code of 
punctures that penetrated the membrane and agar surface, and 
the plates were incubated at 37°C for a further 4 h. Each 
membrane was removed, air dried, and 1 µl of HCF (2 mg/ml of 
proteins) was spotted at one point of the filter and acted as 
control for a positive reaction before the membrane was washed 
in PBST (3 × 15 min) and blocked overnight at 4°C in 5% (w/v) 
skim milk in PBS. Following the blocking step, all incubation 
steps were carried out at room temperature on a moving 
platform with the membranes being washed thoroughly in 3 × 15 
min washes after each step. The membranes were washed in 
PBST, incubated for 2 h with HIRS or MIS (diluted to 1 in 100), 
and further washed 3 × 10 min in PBST. The secondary antibody 
of horseradish peroxidase conjugated sheep anti-mouse Ig 
(Silenus) or goat anti-rabbit IgG (Bio-Rad) was diluted 1:2000 in 
5% (w/v) skim milk in PBST, and incubated with the membranes 
for 2 h. The membranes were developed in 45 ml of PBS 
containing 30 µl of 30% (v/v) hydrogen peroxide and 5ml of the 
chromogenic substrate 4-chloro-1-naphthol (60 mg stock 
solution of 4-chloro-1-naphthol in 20 ml of ice cold methanol) 
after three washes in PBST and a final wash in PBS only. Fusion 
proteins adsorbed to the membranes that were recognized by the 
MIS or HIRS appeared as pink to purple coloured spots, with 
colour intensity indicating immunoreactivity. Positive plaques 
were identified by aligning the membrane with the agar plate, and 
plaques of interest were removed using a sterile Pasteur pipette 
and transferred to 500 µl of sterile SM buffer. Twenty µl 
chloroform was added to the phage stock to lyse the host cells, 
and the stock was stored at 4°C.  
 
Preparation of plasmid DNA by single-clone 
excision 
 
Automatic excision is a process where purified phage particles are 
converted to phagemid (plasmid) by in vito excision using a 
suitable helper phage. A single XL1-blue colony was incubated 
overnight at 30°C in NZY broth (one liter contained 5g NaCl, 2g 
MgSO4·7H2O, 5g yeast extract, 10g casein hydrolysate)) 
containing 0.2% (w/v) maltose. A single XLOLR (strain) E. coli 
(Stratagene) colony was incubated overnight at 30°C in NZY 
broth. The cells were pelleted (1,000 × g, 10 min, RT) and 
resuspended at an OD600nm of 1.0 in 10 mM MgSO4. Washed cell 
(200 µl of XL1-blue MRF cells) were transferred to a sterile 
Falcon 2059 polypropylene tube containing 250 µl of purified 
phage stock (containing >1 × 105 phage particles) and 1 µl of the 
ExAssist helper phage (>1 × 106 pfu/µl) (Stratagene). The tube 
was incubated at 37°C for 15 min, 3 ml NZY broth added and 
incubated for a further 3 h at 37°C with shaking (100 rpm). The 
cells were lysed by heating at 68°C for 20 min and then cellular 
debris was pelleted (1,000 × g, 15 min). The supernatant (10 µl) 
was incubated with 200 µl of washed cells (XLOLR cells) at 37°C 
for 15 min, then 300 µl of NZY broth was added and incubated 
at 37°C for 45min. One hundred µl of infected cells were plated 
(spread) onto LB agar plates containing 50 µg/ml of Kanamycin 
and incubated at 37°C for overnight. Single colonies were 
incubated overnight in 10 ml of LB broth containing kanamycin 
(50 µg/ml) and plasmid DNA was extracted from the cells the 
following day.  
 
Colony immunoassay for initial screening with 
mouse and human sera 
 
The initial tests for each of the positive clones were performed in 
a colony immunoassay. Plaques formed by cloned phage infected 
host bacterial cells were transferred and lifted to a sheet of 
nitrocellulose membrane. The sheet was cut into strips and each 
of the strips was probed using individual mouse infection serum 
and that from a patient with clinically diagnosed CE. The reaction 
procedures including the colour development were the same as 
those used for immunoscreening the cDNA library. 
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Sub-cloning, expression and purification of 
recombinant proteins  
 
Positive clones with diagnostic sensitivity in the initial serum tests 
were sub-cloned into the BamH I (New England BioLabs, 
Beverly, MA) and Not I (NEB) site of the pET-41b(+) 
expression vector (Novagen, Inc.,  Madison, WI). The GST 
fusion proteins were expressed in E. coli BL21(DE3) cells 
induced by 0.2 mM IPTG and affinity purified by GST⋅Bind 
Kits (Novagen) under native conditions according to the 
manufacturer’s instructions. Recombinant GST was obtained by 
expressing plasmid pET-41b(+) vector in BL21(DE3). The 
vector contained GST and S- and 2 × His Tags to facilitate 
purification. The bacterial cells were cultured at 37°C, soluble 
protein production was induced by 0.2 mM IPTG, and purified 
by the same GST affinity purification kit (for details, see Protocol 
1).  
 
SDS-PAGE and immunoblot analysis 
 
Affinity purified GST fusion proteins or concentrated HCF were 
electrophoresed on 12% (w/v) SDS-PAGE gels under reducing 
conditions and transferred onto nitrocellulose membrane. The 
membrane was then cut into strips. Each strip contained about 
0.3 µg recombinant fusion protein or 15 µg HCF proteins. After 
blotting with 5% (w/v) skim milk, the strips were incubated with 
mouse or human test sera (diluted 1:100) for 1 h at 37˚C. After 3 
washes with PBST, the strips were incubated with sheep anti-
mouse whole Ig (Silenus, Amrad Operations Pty Ltd, Melbourne, 
Australia) or goat anti-human IgG (Sigma) conjugate. The strips 
were visualized for colour after development in 4-chloro-1-
naphanol substrate solution for 15 min at room temperature. 
Further details are provided in Protocol 2.  
  
Patients and sera 
Serum samples from patients with surgically confirmed CE were 
collected from different geographical areas and used to assess the 
diagnostic sensitivity of the selected proteins (Table 3). Serum 
samples used for assessing their diagnostic specificity were from 
patients with other proven parasitic infections, including alveolar 
echinococcosis (AE), neurocysticercosis and schistosomiasis 
(Table 3). All sera were stored at -20°C until used. Full clinical 





Quality of sera for screening the cDNA library 
Before screening the cDNA library, the reactivities of the MIS 
and HIRS were tested with HCF antigens by Western blot and 
these reactions were also compared with other sources of sera. 
Native HCF antigens were run on SDS-PAGE, then transferred 
onto a nitrocellulose membrane. The stripped membranes were 
then probed with HIRS, MIS, serum pools from mice infected 
with schistosomiasis and malaria, and serum pools from humans 
with confirmed CE, AE, NCC and schistosomiasis. The MIS and 
HIRS recognized a similar pattern of HCF antigens (Fig. 1); more 
than 12 HCF bands of molecular sizes ranging from 8 to 200 
kDa, including the strongly reacting 8 kDa sub-unit of antigen B 
(12) (Fig. 1, arrowed), were recognized. Pools of sera from 
human subjects with confirmed CE, AE and NCC reacted with 6 
or more HCF components (Fig. 1). 
 
Fig. 1: Western blot analysis showing the recognition of hydatid cyst fluid 
(HCF) antigens of Echinococcus granulosus by different sources of sera. 
Lane M, protein marker; Lane 1, pooled sera from normal mice; Lane 2, pooled 
sera from mice experimentally infected with oncospheres of E. granulosus; Lane 3, 
pooled sera from mice infected with Plasmodium yoelii; Lane 4, pooled sera from 
mice infected with Schistosoma japonicum; Lane 5, pooled normal human sera; Lane 
6, pooled sera from humans with proven cystic hydatid disease infection; Lane 7, 
pooled sera from humans with proven alveolar echinococcosis infection; Lane 8, 
pooled sera from humans with proven neurocysticercosis infection; Lane 9, 
hyperimmune rabbit serum prepared against hydatid cyst fluid antigens. HCF 
antigen B (AgB) is arrowed. Protein standard markers are shown on the left hand 
of the figure. 
 
Construction and titering of the protoscolex cDNA 
library 
 
In order to obtain good quality cDNA, a column was used to 
fractionate the cDNA after the second strand synthesis. cDNAs 
in fractions with sizes greater than 0.5 kb (Fractions 5, 6, 7/8 in 
Fig. 2) were combined and ligated to the λZAP phage vector. 
Clones were randomly selected and amplified by PCR. The 
majority of cDNA inserts were more than 1 kb (1-3.0 kb) in size 
(Fig. 3). The titre of the unamplified protoscolex cDNA library 
was 2.31 × 106 plaque forming units (pfu) per ml. An estimated 
99.5% of the phage in the cDNA library were recombinants. 
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Fig. 2: Size of cDNA synthesised from mRNA isolated from protoscoleces 
of E. granulosus. After the second-strand cDNA was synthesised by adding 2µl 
of [α-32P] dATP to the reaction, the cDNA was fractioned through a CL-2B 
column after being linked with EcoR I adapters and digested with Xho I to create 
an Xho I cut end. Fractions 5 to 11 (1µl of elution) were run on an agarose gel 
and exposed for 4 h to an X-ray film before being developed. Standard RNA 
markers, in nucleotides are shown on the left hand of the figure.  
 
Fig. 3: The cDNA insert sizes of randomly selected clones from the 
protoscolex cDNA library. The cDNA insert sizes were determined by PCR 
using T3 and T7 primers with the PCR products being electrophorezed on a 1% 
(w/v) agarose gel. The size of the DNA fragments (Lanes 1-21) were compared 
with standard DNA ladder (Gibco BRL) (Lane M). 
 
Screening the cDNA library 
 
To identify genes encoding putative immunodiagnostic antigens, 
we first used HIRS to immunoscreen 1.65 × 105 pfu of the 
unamplified E. granulosus protoscolex expression cDNA library. 
Ninety six clones were isolated. Four clones that showed strong 
signals were sequenced (Table 1). All of the four proteins were 
expressed in the phage vector and then lifted to nitrocellulose 
membrane from plate plaques. None of the proteins were 
recognized by MIS or a pool of human CE sera (data not shown). 
 
Table 1 : Clones isolated from the E. granulosus protoscolex cDNA library 
by immunoscreening using a pool of sera from mice experimentally 
infected with oncospheresa and a hyper-immune rabbit serum raised 




Estimated cDNA insert size 
(kb) 
aEgTPx 5 0.661-0.662 
aEpC1 1 0.42 
aEpG5 5 1.8-2.0 
bEgP1 4 1.3-1.8 
bEgP3 5 1.2-1.4 
bEgP5 3 2.1-2.4 
bEgP6 2 2.0-2.2 
 
MIS was then used to immunoscreen the E. granulosus cDNA 
library. Ninety immunogenic clones were isolated by screening 
1.6 × 104 recombinant phages from the unamplified cDNA 
library. Among these, 11 strongly positive clones were excized 
into plasmid vectors and sequenced. Sequencing analysis showed 
that they belonged to three sequence groups, termed EpC1, 
EgTpx and EgG5 (GenBank accession numbers, AF481884, 
AF478688 and Z29489, respectively) (Table 1). Clone EpC1 is a 
novel E. granulosus gene containing a putative ORF of 231 bp 
coding for a protein with a theoretical molecular mass of 8.5 kDa. 
Clone EgTPx contained a putative ORF of 582 bp coding for a 
protein with a theoretical molecular mass of 21.4 kDa. Clone 
EgG5 contained a putative ORF of 1680 bp coding for a protein 
with a theoretical molecular mass of 65.17 kDa. The three 
antigens were subsequently expressed as GST-fusion proteins, 
purified by glutathione-affinity chromatography and assessed for 
diagnostic performance. 
 
Recognition of cDNA clones by mouse and human 
antisera 
 
Phage-expressed proteins were transferred onto nitrocellulose 
strips and then processed by dot Western blotting (Fig. 4). Phage 
plaque dot ELISAs showed that 84% (21 out of 25) mouse 
infection sera reacted with EpC1, 11/25 (44%) with EgG5, 
18/25 (72%) with EgTPx and 23/25 (92%) with the mixture of 
EpC1, EgG5 and EgTPx. 75.6% (34/45) human sera reacted 
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with the mixture of EpC1, EgG5 and EgTPx (data not shown). 
These results indicated that the proteins were recognized by both 
mouse and human infection sera and the reactivities of the mixed 
phage expressed proteins were superior to the individual 
proteins. For diagnostic proposes, the use of natural infection 
serum to screen the cDNA library was considered more 
appropriate than a serum prepared against HCF antigens. 
 
Fig. 4: Conventional Western blot (Panel I) of hydatid cyst fluid antigen B 
(arrowed) and plaque-dot blots of recombinant phages (Panel II) using 
individual sera from 26 mice (numbered at the top of Panel I) infected with 
oncospheres of E. granulosus. Recombinant phage vectors were transfected 
into XL1-Blue bacterial cells (Stratagene), then plated on top of LB plates with 
top agar. After growing the transfected cells for 5 h at 42°C, a nitrocellulose 
membrane was placed on top of the agar. Then the plate was incubated at 37°C 
for a further 4 h. The membrane was washed three times with PBST and cut into 
strips. After blocking in 5% (w/v) skim milk in PBS, the strips were reacted with 
the individual mouse sera and then sheep anti-mouse IgG conjugate (full details 
are described same as Western blotting in Protocol 2). The strips were developed 
with 4-chloro-1-naphthol substrate. Recombinant phage are EgTPx (a), EgG5 (b), 
EpC1 (c), and a mixture of EgTPx, EgG5 and EpC1 (d). The numbers of hydatid 
cysts resulting from oncospheral infection in each of the mice are shown between 
Panels I and Panels II. Protein standard markers (M) (in kDa) are shown on the 
left side of Panel I. 
 
Cloning and expression of cDNAs 
 
Having shown the potential serodiagnostic value of their 
expression products, the EpC1, EgTPx, EgG5 cDNAs were 
subcloned into the pET-41b(+) vector and expressed as GST 
fusion proteins induced with 0.2 mM IPTG for 3 h at 37˚C. The 
soluble fusion proteins that resulted were affinity purified. Fig. 5a 
shows the expression and purification of the recombinant 
proteins on a Coomassie-stained 12% SDS-gel, run under 
reducing conditions. The affinity purified fusion proteins were 
clearly recognized by a pool of sera from CE patients (Fig. 5b) 
and MIS (Fig. 5c).  
 
Fig. 5: Expression, purification (Panel A, SDS-PAGE stained by 
Coomassie blue) and Western blotting of recombinant proteins for 
diagnosis of cystic echinococcosis (CE) with a pool of sera from patients 
confirmed with CE (Panel B), and a pool of sera from mice experimentally 
infected with oncospheres of E. granulosus (Panel C). Lane El, bacterial 
lysate containing EpC1-GST; Lane Ep, affinity purified EpC1-GST; Lane Tl, 
bacterial lysate containing EgTPx-GST; Lane Tp, affinity purified EgTPx-GST; 
Lane Gl, bacterial lysate containing EgG5-GST; Lane Gp, affinity purified EgG5-
GST. Protein standard markers (in kDa) are shown on the left side of the Panels. 
 
Diagnostic performance of rEpC1, EgTPx and EgG5 
using immunoblotting 
 
Immunoblotting (IB) was used to test the diagnostic sensitivity of 
rEpC1-GST, rEgTPx-GST, rEgG5-GST and HCF antigens 
against 25 individual MIS sera (mice infected with E. granulosus 
oncospheres) (Table 2). Of these, 23 (92%) recognized rEpC1-
GST, whereas 22 (88%) of the sera reacted with HCF AgB. 
Sensitivity was much lower with rEgTPx-GST (64%) and rEgG5-
GST (40%). Then, the same proteins were tested in an IgG-IB 
with individual sera from patients with clinically diagnosed CE, 
patients who had other helminthic infections, patients with other 
liver diseases and subjects who were clinically normal. The overall 
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results are summarized in Table 3 and show clearly that EpC1 was 
the most diagnostically useful for detecting CE infection. In total, 
the EpC1 diagnostic antigen was tested on 896 sera including sera 
from 324 CE, 172 NCC, 89 AE, 241 other infections/liver cancer 
cases and 70 confirmed negative controls. The overall sensitivity 
obtained with EpC1 was 92.2% and specificity was 95.6% (8).
Table 2: Western blot analysis of the three selected antigens, HCF-AgB and GST using 25 sera from mice experimentally infected with oncospheres of E. 
granulosus. 
Protein Number of positively reacting sera % 
HCF-AgB 22 88 
GST 0 0 
EpC1-GST 23 92 
EgTPx-GST 16 64 
EgG5-GST 10 40 
 
Table 3. Diagnostic performance, by immunoblotting, of the test proteins screened against human sera clinically confirmed with an infection or other clinical 
presentation. 
 Number of positive sera/total sera tested (% positivity rate) 
 CE AE NCC Schist Others Healthy 
GST 5/116 (4.3) 2/89 (2.2) 7/172 (4.1) 1/78 (1.3) 2/153 (1.3) 1/70 (1.4) 
HCF-AgB 98/116 (84.5) 7/9 (77.8) 14/100 (14.0) 5/50 (10.0) 5/119 (4.2) 3/70 (4.3) 
EpC1-GST 107/116 (92.2) 4/89 (4.5) 16/172 (9.3) 1/78 (1.3) 1/153 (0.65) 3/70 (4.3) 
EgTPx-GST 39/100 (39.0) 50/89 (56.2) 14/72 (19.4) 0/28 (0) 5/29 (17.2) 4/20 (20.0) 




Sufficient quantity and high quality mRNA was crucial for 
construction of the E. granulosus cDNA library. Accordingly, E. 
granulosus protoscoleces were aspirated from hydatid cysts within 
2 h after slaughter of infected sheep. After a final wash with PBS, 
the protoscoleces were placed into a liquid nitrogen container 
directly and stored in the container until use. The steps for RNA 
extraction were undertaken under very cold conditions before 
adding the TRIZOL Reagent. The mortar and pestle for grinding 
the protoscolex tissue were pre-cooled with liquid nitrogen. The 
tissue was ground by continuously adding liquid nitrogen to keep 
the mortar cool. Once the tissue was powdered, the powder was 
poured into a tube containing TRIZOL Reagent. Careful 
fractionation of cDNA was also important for constructing the 
high quality cDNA library containing large fragments or full 
length cDNA sequences. 
 
Several different types of pooled sera were tested with crude 
hydatid cyst antigens by Western blot (Fig. 1) in order to 
determine the optimum serum for screening the E. granulosus 
cDNA library. The results showed that many HCF antigens 
could be recognized by MIS and HIRS, and by human infection 
sera. The CKW mouse, which is widely used in China for medical 
science research, is a good experimental animal model for the 
primary infection of hydatid disease as shown in previous studies 
(9). 25 out of 26 mice were successfully infected with E. granulosus 
oncospheres producing from 4 to 100 cysts (8). The mouse sera 
were also individually probed against HCF antigens in Western 
Blot analysis which showed that most of the sera (22/25) were 
able to strongly recognize HCF antigens (8).  
 
HIRS was used initially to screen the cDNA library. 1.65 × 105 
plaques were probed with HIRS, which was more than 10 times 
the number of plaques (1.6 × 104) screened by MIS. Almost the 
same numbers of positive clones (96 vs 90) were obtained with 
the two screens, which indicated that infection serum was more 
sensitive for this purpose than the hyper immune serum. The 
clones strongly reacting with HIRS belonged to four groups 
designated as EgP1, EgP3, EgP5 and EgP6 (Table 1). EgP1 is a 
partial severin sequence and the others are novel genes. EgP6 has 
a sequence with 55 amino acid repeated 7 times. The repeat 
sequence has no motif similarity in the GenBank™ database. The 
dot-ELISA using phage plaques showed that those recombinant 
proteins were not recognized by infection sera from mice or 
humans. This was further evidence that infection serum is 
preferable to hyper immune serum in screening a cDNA library 
for isolating genes encoding putatively diagnostic antigens. We 
did not undertake any further expression or serological analysis of 
these four groups of clones. 
 
The most frequent cross-reactions in immunodiagnostic assays 
for cystic echinococcosis are due to E. multilocularis and T. solium 
(13). Antigen 5, one of the two major antigenic lipoprotein 
components in HCF, cross-reacts with antibodies in sera from 
subjects infected with E. multilocularis, E. vogeli, T. solium and other 
parasites (14). The other dominant lipoprotein, antigen B (15, 16) 
is more specific although cross reactivity occurs with serum 
antibodies in patients infected with E. multilocularis and E. vogeli 
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(17), and T. solium (14). In our study, a pool of sera from 9 AE 
patients also showed reactivity with antigen B-like proteins in 
HCF (Fig. 1).  
 
We used immunoblotting (IB) as the basis of our serodiagnostic 
method due to its simplicity and sensitivity (18-20). Furthermore, 
IB directly shows the reactivity of target protein with a positive 
serum sample. We compared rEpC1-GST with HCF antigen B to 
evaluate its diagnostic performance. Antigen B, banding at 
approximately 8 kDa in SDS-PAGE, was used for comparative 
purposes as it has been shown to be a useful marker for diagnosis 
of CE (21-23). The overall sensitivity (92.2%) and specificity 
(95.6%) obtained with rEpC1-GST indicate that this protein has 
probably achieved a better level of diagnostic performance than 
other reported reagents, particularly when the large number of 
serum samples tested are taken into consideration. We are 
currently evaluating the performance of rEpC1 in an ELISA 
format. 
 
Although the GST tag present on the rEpC1-GST fusion protein 
was derived from S. japonicum, only one of 88 sera from patients 
with schistosomiasis (20 confirmed S. japonicum cases; 68 
confirmed S. mansoni cases) reacted with rEpC1-GST (8). The 
reasons for this lack of reactivity are unclear but it may be due to 
the fact that the E. coli expressed GST did not contain 
conformational epitopes required for recognition by the 
schistosomiasis infection sera or the antigenicity of GST was too 
weak to be recognized. The rEpC1-GST fusion protein was 
digested with enterokinase to remove GST using a recombinant 
enterokinase kit (Novagen). Forty-five sera from confirmed CE 
cases were used to compare the reactivity of rEpC1 with rEpC1-
GST by IB. Sensitivity, in terms of positively reacting sera, was 
similar with both antigens but weaker signals were obtained with 
rEpC1 (data not shown). The EpC1 cDNA was also subcloned 
into the pCAL-n vector (Stratagene) to express rEpC1 as a fusion 
protein with calmodulin binding protein (rEpC1-CBP). Again 
weaker signals were obtained (data not shown) indicating that the 
presence of GST enhanced the sero-reactivity of rEpC1. This 
may have been due to the GST presenting a confirmational 
structure with the epitope(s) of EpC1, which resulted in an 
increase in the signal. 
 
CE is characterized by the triggering of an intense humoral 
response with a corresponding rise in the titers of specific 
antibodies (6). Such a response is encouraging for the 
development of a CE serodiagnostic assay but available antigens 
do not provide an appropriate level of sensitivity or specificity. 
Furthermore, due to the lack of standardization of these antigens 
and a lack of concordance among the various tests available for 
CE serology, a diagnostic assay for routine laboratory diagnosis 
of hydatidosis is not yet available. A rapid, simple antibody-based 
test incorporating a single defined recombinant E. granulosus 
antigen is required urgently for diagnosis of early CE infection in 
humans, ensuring early treatment, and for discrimination from 
AE infection. We have described the cloning, expression and 
purification of a small panel of E. granulosus antigenic 
components resulting in the identification of a suitable molecule, 
rEpC1-GST that can provide the requisite levels of specificity 
and sensitivity, and applied it in a simple immunoblot format for 
CE diagnosis. We plan to extend the diagnostic potential of the 
test by improving its specificity without affecting sensitivity, 
thereby supporting its utility for routine application in the clinic, 
laboratory and in the field for community surveillance surveys 
that monitor CE control programs. Further, as there is no assay 
currently available for serodiagnosis of CE in livestock animals 
that are responsible for the transmission of E. granulosus to 
humans, our objective of developing a rapid test, based on the 
EpC1 protein, is timely. The assay would allow the monitoring of 
animals imported into countries free from hydatidosis and as an 
aid to countries where control schemes for the disease are in 
operation. 
 
Given the diagnostic properties of EpC1 and the fact that large 
quantities of the protein in pure form can be produced, the 
antigen should be readily amenable to any commercial protocols 
currently available for antibody detection applicable both 
clinically and to detect infected livestock. We plan future 
simplification of the test to a dipstick dye assay format that will 
be rapid, cheap and not requiring any equipment. Such assays 
have been developed for the detection of antibodies against a 
range of infectious agents including Schistosoma (24) and 
Leishmania (25). 
 
The strategy we used for isolation of E. granulosus cDNAs 
expressing proteins with serodiagnostic value and their 
application in antibody-based detection assays may also prove 
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EpC1-GST fusion protein expression 
 
1. Pick a colony from a plate using a tooth pick and inoculate into 30 ml LB plus kanamycin antibiotic at a final concentration of 30 
µg/ml. Culture overnight at 37˚C. 
2. Dilute the culture 10 times to 300 ml LB containing kanamycin at a final concentration of 30 µg/ml and further grow the bacteria 
by measuring the optical density at 600nm (OD600). 
3. Induce recombinant protein expression by adding isopropyl bD-thiogalactopyranoside (IPTG) at a final concentration of 0.2 mM 
when the OD600 reaches 0.6. Further culture for 4-5 h and harvest cells by centrifugation for 30 minutes at 5000 rpm. Use the GS-
3 rotor in a Sorvall (or the JA-10 in a Beckman) centrifuge.  
4. Discard the supernatant and resuspend the cell pellet with GST binding buffer (25 mM Tris pH 7.5, 150 mM NaCl, 10 mM DTT, 1 
mM EDTA and 1 mm PMSF). Use about 10 ml of GST binding buffer per g of wet cells. 
5. After three frozen-thaw cycles, ultrasonicate for 3 min using the standard large attachment head (90% output and 50% duty cycle). 
Repeat 3 times. Cool on ice for 3 min after each sonication. 
6. Centrifuge for 30 min at 12,000g at 4˚C. 
7. Load and run 10 µl of supernatant on a SDS-PAGE gel to estimate the expression rate of the fusion protein. Measure the 
concentration of protein in the lysate. 
8. Dilute the lysate to 1 mg/ml of total protein with GST binding buffer and load onto a gluthathione sepharose column (Novagen). 
Normally 2 ml of gluthatione sepharose (50% slurry) can bind 10 mg of recombinant protein. Calculate the volume of lysate 
needed and keep the sample at 4˚C when passing through the gluthathione sepharose column.  
9. Wash the column by flowing through with GST binding buffer at 4˚C until no protein can be detected using the Protein Assay Dye 
Reagent (Bio-Rad) (26). We use the mini measure method: 5 µl of flow sample is added to 250 µl of diluted (1 in 5 dilution) Protein 
Assay Dye Reagent in a 96-wall plate. No color change indicates no protein remains in the flow sample. 
10. EpC1-GST fusion protein is eluted by adding elution buffer (50 mM Tris-HCl (pH 8.0) with 10 mM reduced glutathione) at a flow 
rate of 1 ml/min until no protein remains on testing with the protein assay dye reagent.  
11. Measure the protein concentration in the eluted sample, aliquot into tubes and store at -70˚C until use. 
 




We use 12% (w/v) SDS-PAGE gels with the Bio-Rad Protean Minigel system. Full details for preparation of the SDS-PAGE gels can 
be found in Chapter 10 of reference 27. We routinely run whole-well gels, loading 10µg protein per gel. Then, the protein is transferred 
onto nitrocellulose membrane for Western blotting. 
 
Western blotting (immunoblotting) 
 
1. Once recombinant proteins are separated using SDS-PAGE, place a nitrocellulose membrane on the gel and, using electrophoresis, 
transfer the protein bands onto the nitrocellulose membrane (27).  
2. Block the membrane with 5% (w/v) skim milk in PBS for 1 h at 37˚C and cut the membrane into strips 2.5 mm wide with 32 strips 
containing 0.3 µg protein per strip. 
3. Incubate the nitrocellulose membrane with human or animal test serum. The test serum is normally diluted 1 in 100 with 5% (w/v) 
skim milk in PBST (PBS containing 0.05% (v/v) Tween-20). Incubation can be undertaken at 37oC, or alternatively, over-night at 
4oC on a rocking platform.  
4. Incubate the nitrocellulose membrane with an antibody-enzyme conjugate (secondary antibody) after washing 3 × 15 min on a 
rocking platform in PBST. We routinely use sheep anti-human IgG (Sigma), or sheep anti-mouse IgG (Silenus, AMRAD, 
Melbourne, Australia) conjugate diluted 1 in 1000 with 5% (w/v) skim milk in PBST.  
5. The location of the antibody-binding band is revealed by incubating the membrane with a colorless substrate* at room temperature 
for 15 min. The reaction is stopped with three washes with water. 
6. A purple or dark purple colour occurring at the position of the EpC1-GST band represents a positive reaction.  
 
* - For stock solution, dissolve 60 mg of 4-chloro-1-naphthol in 20 ml cold methanol and the solution can be stored at -20°C for a 
month. For the working solution, dilute the stock solution 1 in 10 with PBS and add 6 µl of hydrogen peroxide (30% (v/v) solution) per 
10 ml of the working solution. 
